These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 27536891

  • 1. The impact of lymph node dissection and adjuvant chemotherapy on survival: A nationwide cohort study of patients with clinical early-stage ovarian cancer.
    Kleppe M, van der Aa MA, Van Gorp T, Slangen BF, Kruitwagen RF.
    Eur J Cancer; 2016 Oct; 66():83-90. PubMed ID: 27536891
    [Abstract] [Full Text] [Related]

  • 2. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
    Powless CA, Aletti GD, Bakkum-Gamez JN, Cliby WA.
    Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
    [Abstract] [Full Text] [Related]

  • 3. Clinical Practice of Adjuvant Chemotherapy in Patients with Early-Stage Epithelial Ovarian Cancer.
    Frielink LM, Pijlman BM, Ezendam NP, Pijnenborg JM.
    Chemotherapy; 2016 Sep; 61(6):287-94. PubMed ID: 27074010
    [Abstract] [Full Text] [Related]

  • 4. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
    Tu H, Huang H, Huang QD, Li Z, Feng YL, Liu JH.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
    [Abstract] [Full Text] [Related]

  • 5. Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study.
    Minig L, Heitz F, Cibula D, Bakkum-Gamez JN, Germanova A, Dowdy SC, Kalogera E, Zapardiel I, Lindemann K, Harter P, Scambia G, Petrillo M, Zorrero C, Zanagnolo V, Rebollo JMC, du Bois A, Fotopoulou C.
    Ann Surg Oncol; 2017 Sep; 24(9):2720-2726. PubMed ID: 28608122
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lymph node metastasis in grossly apparent stages I and II epithelial ovarian cancer.
    Nomura H, Tsuda H, Susumu N, Fujii T, Banno K, Kataoka F, Tominaga E, Suzuki A, Chiyoda T, Aoki D.
    Int J Gynecol Cancer; 2010 Apr; 20(3):341-5. PubMed ID: 20375794
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer.
    Wang M, He Y, Shi L, Shi C.
    Eur J Gynaecol Oncol; 2011 Apr; 32(2):171-7. PubMed ID: 21614907
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of Factors Affecting Lymph Node Metastasis in Clinical Stage I-II Epithelial Ovarian Cancer.
    Erdem B, Yüksel IT, Peker N, Ulukent SC, Aşıcıoğlu O, Özaydin IY, Ülker V, Akbayir O.
    Oncol Res Treat; 2018 Apr; 41(7-8):444-448. PubMed ID: 29975960
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The Significance of Lymph Node Dissection in Patients with Early Epithelial Ovarian Cancer.
    Bao R, Olivier M, Xiang J, Ye P, Yan X.
    Ann Ital Chir; 2024 Apr; 95(4):628-635. PubMed ID: 39186355
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma.
    Mahdi H, Moslemi-Kebria M, Levinson KL, Gojayev A, Lockhart D, Ali-Fehmi R, Munkarah AR.
    Int J Gynecol Cancer; 2013 Sep; 23(7):1226-30. PubMed ID: 23736258
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.